Global DTP Vaccines Market Report 2024

DTP Vaccines Global Market Report 2024 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 250 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
DTP Vaccines Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

DTP Vaccines Market Definition And Segments

Diphtheria, Tetanus, Pertussis (DTP) vaccines refer to a combination vaccine given intramuscularly to protect children under the age of 7 from diphtheria, tetanus, and whooping cough. It aids kids in acquiring resistance to the three bacterial illnesses, diphtheria, tetanus, and pertussis, which are all fatal.

The main types of products in DTP vaccines are DTaP, TD, and Tdap. Diphtheria, tetanus, and whooping cough (DTaP) vaccines help children under the age of seven build protection against three lethal bacteria-borne diseases: diphtheria, tetanus, and whooping cough (pertussis). The different types of diseases include diphtheria, pertussis, and tetanus and involve various sectors such as hospitals, clinics, and vaccination centers.

The DTP vaccines market covered in this report is segmented –

1) By Product type: DTaP, TD, Tdap

2) By Disease: Diphtheria, Pertussis, Tetanus

3) By End-User: Hospitals, Clinics, Vaccination Centers

The DTP vaccines market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.56 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increase in healthcare access, continuous protection towards infectious diseases and rising awareness of immunization.

The DTP vaccines market size is expected to see strong growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to strong late-stage pipeline and new drug approvals, increased healthcare expenditure and immunization policies to eradicate endemic diseases. Major trends in the forecast period include focusing on development of combination vaccines, investing extensively in R&D activities, using artificial intelligence (AI) in vaccine development and focusing on strategic acquisitions.

Government Initiatives Propel Development And Adoption Of DTP Vaccines

Governments all over the world are encouraging the development of DTP vaccines in order to prevent the spread of the disease. Countries such as India have the Universal Immunization Programme that aims to provide recommended vaccines against tuberculosis, polio, and other diseases including diphtheria, tetanus, and whooping cough for all Indian children. The country regularly conducts vaccination drives, which are expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.

Rising Healthcare Expenditure Fuels Growth In The DTP Vaccine Market

The increasing healthcare expenditure is expected to propel the growth of the DTP vaccine market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services, including medical equipment, hospital services, physician services, prescription drugs, and public health activities. Healthcare expenditure is instrumental in creating an environment that fosters the development, production, distribution, and effective utilization of DTP vaccines. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Furthermore, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the DTP vaccine market.

Major companies operating in the DTP vaccines market report are GlaxoSmithKline, Sanofi, Merck & Co Inc., Meiji Holdings Co., Ltd., Shenzhen Kangtai Biological Products, Serum Institute of India Pvt Ltd., Sun Pharmaceutical Industries Ltd., AJ Vaccines, PT Bio Farma, Bio Med, Sinergium Biotech SA, Teuto Brasileiro, Amgen, Roche, BioFabri, Sinopharm, Chongqing Zhifei, Hualan Biological Engineering Inc., Ezequiel Dias Foundation (FUNED), BioKangtai, Uniao Quimica, Valneva SE, The Abu Dhabi Health Services Company (SEHA), ImevaX GmbH, Cristalia, Bharat Biotech, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Connaught Laboratories Inc., Biolab Farmaceutica, Massbiologics, Beijing Tiantan Biological Products Co Ltd., Butantan Institute, C.R.I. Kasauli, Bayer, Pfizer, Abbott Laboratories, Serum Institute of India Pvt Ltd., Novartis, Wyeth-Ayerst, Dano Vaccines, Merck Serono Middle East, Hypermarcas, AstraZeneca, Grifols, Sinovac Biotech Ltd., AbbVie Inc., Apotex, GreenSignal Bio Pharma Private Limited (GSBPL), Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG, Boehringer Ingelheim, CanSino Biologics, Gilead Sciences, Panacea Biotec Ltd., Fiocruz, Johnson & Johnson, Walvax biotechnology, BioNTech, EMS Pharma, Mylan, National Administration of Laboratories and Institutes of Health (ANLIS), Zentiva, Afrigen Biologics & Vaccines

DTP Vaccine Market Faces Challenges Due To Inadequate Access In Developing Nations

Inadequate vaccine access in developing countries is expected to limit the growth of the global DTP vaccine market. According to the World Health Organization’s global estimates, around 19.4 million infants do not have access to DTP vaccines, and around 60% of these children live in underdeveloped and developing countries. Countries such as the Central African Republic, Chad, Equatorial Guinea, Guinea, Samoa, Somalia, South Sudan, the Syrian Arab Republic, and Ukraine have less than 50% coverage of DTP vaccination. Lack of access to vaccines in underdeveloped countries is expected to hamper market growth.

Innovative In Vaccine Paving The Way For Enhanced Protection Of Adolescents, Adults, And Unborn Children

Major companies operating in the diphtheria, tetanus, and pertussis (DTP) vaccine market are focusing on developing innovative vaccines such as BOOSTRIX to gain a competitive edge in the market. BOOSTRIX is a vaccine used to help protect adolescents (ages 10–18) and adults against certain diseases caused by bacteria called Bordetella pertussis, diphtheria, and tetanus. It's a combination vaccine that helps prevent whooping cough (pertussis), diphtheria, and tetanus. For instance, in October 2022, GSK PLC, a UK-based biotechnology and pharmaceutical company, launched BOOSTRIX, which received approval from the US Food and Drug Administration (FDA). This is the first vaccine that has been specifically licensed for use by pregnant women to protect unborn children from illness. It enhances the mother's antibodies, which are passed on to the growing baby when given during pregnancy.

Advancements In DTP Combination Vaccines Streamlining Immunization For Enhanced Protection

Companies in the DTP vaccines market are increasingly investing in manufacturing DTP combination vaccines, which reduce the need for multiple vaccination shots for immunization against infectious diseases. DTP combination vaccines such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib), and hexavalent (DTP-Hib-HepB-IPV) are available to provide the same protection as individual vaccine shots given separately.

GSK Plc Strengthens Portfolio With Acquisition Of Affinivax, Inc. And Advances Next-Generation Pneumococcal Vaccine Development

In August 2022, GSK PLC, a UK-based biotechnology and pharmaceutical company, acquired Affinivax, Inc. for $2.1 billion. With this acquisition, GSK is advancing its objective of assembling a potent portfolio of specialized drugs and vaccines. It comprises AFX3772, a candidate for the next-generation 24-valent pneumococcal vaccine that is based on the incredibly ground-breaking Multiple Antigen Presenting System (MAPSTM) platform technology and is currently in phase II development. Affinivax, Inc. is a US-based biotechnology company producing preventative and therapeutic vaccines using a next-generation approach to vaccine technology.

North America was the largest region in the DTP vaccines market in 2023. The regions covered in the DTP vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the DTP vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The DTP vaccine market consists of sales of Daptacel, Infanrix, Kinrix, Paediarix, Pentacel, Quadracel, and Vaxelis vaccines. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The DTP vaccines market research report is one of a series of new reports from The Business Research Company that provides DTP vaccines market statistics, including global market size, regional shares, competitors with a DTP vaccines market share, detailed DTP vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the DTP vaccines industry. This DTP vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

DTP Vaccines Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $6.56 billion
Revenue Forecast In 2033 $8.63 billion
Growth Rate CAGR of 7.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product type: DTaP, TD, Tdap
2) By Disease: Diphtheria, Pertussis, Tetanus
3) By End-User: Hospitals, Clinics, Vaccination Centers
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled GlaxoSmithKline; Sanofi; Merck & Co Inc; Meiji Holdings Co., Ltd; Shenzhen Kangtai Biological Products; Serum Institute of India Pvt Ltd; Sun Pharmaceutical Industries Ltd; AJ Vaccines; PT Bio Farma; Bio Med; Sinergium Biotech SA; Teuto Brasileiro; Amgen; Roche; BioFabri; Sinopharm; Chongqing Zhifei; Hualan Biological Engineering Inc; Ezequiel Dias Foundation (FUNED); BioKangtai; Uniao Quimica; Valneva SE; The Abu Dhabi Health Services Company (SEHA); ImevaX GmbH; Cristalia; Bharat Biotech; Bio-Manguinhos–Institute of Technology on Immunobiologicals; Connaught Laboratories Inc; Biolab Farmaceutica; Massbiologics; Beijing Tiantan Biological Products Co Ltd; Butantan Institute; C.R.I. Kasauli; Bayer; Pfizer; Abbott Laboratories; Serum Institute of India Pvt Ltd; Novartis; Wyeth-Ayerst; Dano Vaccines; Merck Serono Middle East; Hypermarcas; AstraZeneca; Grifols; Sinovac Biotech Ltd; AbbVie Inc; Apotex; GreenSignal Bio Pharma Private Limited (GSBPL); Teva Pharmaceutical Industries Ltd F. Hoffmann-La Roche AG; Boehringer Ingelheim; CanSino Biologics; Gilead Sciences; Panacea Biotec Ltd; Fiocruz; Johnson & Johnson; Walvax biotechnology; BioNTech; EMS Pharma; Mylan; National Administration of Laboratories and Institutes of Health (ANLIS); Zentiva; Afrigen Biologics & Vaccines
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. DTP Vaccines Market Characteristics

    3. DTP Vaccines Market Trends And Strategies

    4. DTP Vaccines Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global DTP Vaccines Market Size and Growth

    5.1. Global DTP Vaccines Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global DTP Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global DTP Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. DTP Vaccines Market Segmentation

    6.1. Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    DTaP

    TD

    Tdap

    6.2. Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diphtheria

    Pertussis

    Tetanus.

    6.3. Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Clinics

    Vaccination Centers

    7. DTP Vaccines Market Regional And Country Analysis

    7.1. Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific DTP Vaccines Market

    8.1. Asia-Pacific DTP Vaccines Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China DTP Vaccines Market

    9.1. China DTP Vaccines Market Overview

    9.2. China DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India DTP Vaccines Market

    10.1. India DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan DTP Vaccines Market

    11.1. Japan DTP Vaccines Market Overview

    11.2. Japan DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia DTP Vaccines Market

    12.1. Australia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia DTP Vaccines Market

    13.1. Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea DTP Vaccines Market

    14.1. South Korea DTP Vaccines Market Overview

    14.2. South Korea DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe DTP Vaccines Market

    15.1. Western Europe DTP Vaccines Market Overview

    15.2. Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK DTP Vaccines Market

    16.1. UK DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany DTP Vaccines Market

    17.1. Germany DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France DTP Vaccines Market

    18.1. France DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy DTP Vaccines Market

    19.1. Italy DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain DTP Vaccines Market

    20.1. Spain DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe DTP Vaccines Market

    21.1. Eastern Europe DTP Vaccines Market Overview

    21.2. Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia DTP Vaccines Market

    22.1. Russia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America DTP Vaccines Market

    23.1. North America DTP Vaccines Market Overview

    23.2. North America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA DTP Vaccines Market

    24.1. USA DTP Vaccines Market Overview

    24.2. USA DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada DTP Vaccines Market

    25.1. Canada DTP Vaccines Market Overview

    25.2. Canada DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America DTP Vaccines Market

    26.1. South America DTP Vaccines Market Overview

    26.2. South America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil DTP Vaccines Market

    27.1. Brazil DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East DTP Vaccines Market

    28.1. Middle East DTP Vaccines Market Overview

    28.2. Middle East DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa DTP Vaccines Market

    29.1. Africa DTP Vaccines Market Overview

    29.2. Africa DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. DTP Vaccines Market Competitive Landscape And Company Profiles

    30.1. DTP Vaccines Market Competitive Landscape

    30.2. DTP Vaccines Market Company Profiles

    30.2.1. GlaxoSmithKline

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Sanofi

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck & Co Inc

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Meiji Holdings Co., Ltd

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Shenzhen Kangtai Biological Products

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. DTP Vaccines Market Other Major And Innovative Companies

    31.1. Serum Institute of India Pvt Ltd

    31.2. Sun Pharmaceutical Industries Ltd

    31.3. AJ Vaccines

    31.4. PT Bio Farma

    31.5. Bio Med

    31.6. Sinergium Biotech SA

    31.7. Teuto Brasileiro

    31.8. Amgen

    31.9. Roche

    31.10. BioFabri

    31.11. Sinopharm

    31.12. Chongqing Zhifei

    31.13. Hualan Biological Engineering Inc

    31.14. Ezequiel Dias Foundation (FUNED)

    31.15. BioKangtai

    32. Global DTP Vaccines Market Competitive Benchmarking

    33. Global DTP Vaccines Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The DTP Vaccines Market

    35. DTP Vaccines Market Future Outlook and Potential Analysis

    35.1 DTP Vaccines Market In 2028 - Countries Offering Most New Opportunities

    35.2 DTP Vaccines Market In 2028 - Segments Offering Most New Opportunities

    35.3 DTP Vaccines Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: GlaxoSmithKline Financial Performance
  • Table 75: Sanofi Financial Performance
  • Table 76: Merck & Co Inc Financial Performance
  • Table 77: Meiji Holdings Co., Ltd Financial Performance
  • Table 78: Shenzhen Kangtai Biological Products Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: GlaxoSmithKline Financial Performance
  • Figure 75: Sanofi Financial Performance
  • Figure 76: Merck & Co Inc Financial Performance
  • Figure 77: Meiji Holdings Co., Ltd Financial Performance
  • Figure 78: Shenzhen Kangtai Biological Products Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Immuno-Oncology Drugs Global Market Report 2024 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Companion Animal Veterinary Vaccines Global Market Report 2024 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Liposomal Drug Delivery Devices Global Market Report 2024 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Therapeutic Proteins Global Market Report 2024 – By Product Type (Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Protein Diagnostics), By Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Vaccines Global Market Report 2024 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report

Frequently Asked Questions

What is the definition of the DTP vaccines market?

DTP vaccines refer to a combination vaccine given intramuscularly to protect children under the age of 7 from diphtheria, tetanus, and whooping cough. It aids kids in acquiring resistance to the three bacterial illnesses, diphtheria, tetanus, and pertussis, which are all fatal. For further insights on the DTP vaccines market, request a sample here

How will the DTP vaccines market drivers and restraints affect the DTP vaccines market dynamics? What forces will shape the DTP vaccines industry going forward?

The DTP vaccines market growth is aided by governments all over the world are encouraging the development of DTP vaccines in order to prevent the spread of the diseases. However, some DTP vaccines market restraints include inadequate vaccine access in developing countries. For further insights on the DTP vaccines market, request a sample here

What is the forecast market size or the forecast market value of the DTP vaccines market?

The DTP vaccines market is expected to reach $7.79 billion in 2027 at a rate of 5.1%. For further insights on the DTP vaccines market, request a sample here

How is the DTP vaccines market segmented?

The global DTP vaccines market is segmented as
1) By Product Type: DTaP, TD, Tdap
2) By Disease: Diphtheria, Pertussis, Tetanus.
3) By End User: Hospitals, Clinics, Vaccination Centers
For further insights on the DTP vaccines market, request a sample here

Which region has the largest share of the DTP vaccines market? What are the largest region's market size and growth rate?

North America was the largest region in the DTP vaccines market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Who are the major players in the DTP vaccines market?

Key competitors in the DTP vaccines market are, Merck & Co, Sanofi, GSK, Lanzhou Institute of Biological Products, Novartis AG, Pfizer Inc, Johnson & Johnson, Seqirus, AJ Vaccines, Bionet-Asia, Massbiologics, Meiji Holdings Co. Ltd., Panacea Biotec Ltd, Serum Institute of India Pvt. Ltd., Wyeth, Chiron Pharmaceutical Pvt Ltd, Protein Sciences Corporation, Astellas Pharma US Inc, AstraZeneca, Emergent BioSolutions Inc. For further insights on the DTP vaccines market, request a sample here.

What are the key trends in the DTP vaccines market?

Major trends influencing the DTP vaccines market include increasingly investing in manufacturing DTP combination vaccines, which reduce the need for multiple vaccination shots for immunisation against infectious diseases. DTP combination vaccines such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib), and hexavalent (DTP-Hib-HepB-IPV) are available to provide the same protection as individual vaccine shots given separately. For further insights on the DTP vaccines market, request a sample here.

What are the major opportunities in the DTP vaccines market? What are the strategies for the DTP vaccines market?

For detailed insights on the major opportunities and strategies in the DTP vaccines market, request a sample here.

How does the DTP vaccines market relate to the overall economy and other similar markets?

For detailed insights on DTP vaccines market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the DTP vaccines industry?

For detailed insights on the mergers and acquisitions in the DTP vaccines industry, request a sample here.

What are the key dynamics influencing the DTP vaccines market growth? SWOT analysis of the DTP vaccines market.

For detailed insights on the key dynamics influencing the DTP vaccines market growth and SWOT analysis of the DTP vaccines industry, request a sample here.